发明申请
US20080287496A1 1-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels
审中-公开
1-氧代和1,3-二氧代异吲哚啉和减少炎症细胞因子水平的方法
- 专利标题: 1-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels
- 专利标题(中): 1-氧代和1,3-二氧代异吲哚啉和减少炎症细胞因子水平的方法
-
申请号: US11827802申请日: 2007-07-13
-
公开(公告)号: US20080287496A1公开(公告)日: 2008-11-20
- 发明人: Hon-Wah Man , George W. Muller
- 申请人: Hon-Wah Man , George W. Muller
- 专利权人: Celgene Corporation
- 当前专利权人: Celgene Corporation
- 主分类号: A61K31/454
- IPC分类号: A61K31/454 ; A61P29/00 ; A61P35/00
摘要:
1-Oxo- and 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindolines substituted in the 4- and/or 7-position of the isoindoline ring and optionally further substituted in the 3-position of the 2,6-dioxopiperidine ring reduce the levels of inflammatory cytokines such as TNFα in a mammal. A typical embodiment is 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
信息查询
IPC分类: